Nuveen Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-294,396
| Closed | -$17.3M | – | 3335 |
|
|
2023
Q4 | $17.3M | Buy |
294,396
+15,955
| +6% | +$937K | 0.01% | 1248 |
|
|
2023
Q3 | $12.1M | Buy |
278,441
+46,556
| +20% | +$2.03M | ﹤0.01% | 1357 |
|
|
2023
Q2 | $8.38M | Sell |
231,885
-28,524
| -11% | -$1.03M | ﹤0.01% | 1620 |
|
|
2023
Q1 | $9.68M | Buy |
260,409
+23,135
| +10% | +$860K | ﹤0.01% | 1510 |
|
|
2022
Q4 | $10.8M | Buy |
237,274
+96,877
| +69% | +$4.39M | ﹤0.01% | 1441 |
|
|
2022
Q3 | $9.81M | Sell |
140,397
-3,447
| -2% | -$241K | ﹤0.01% | 1480 |
|
|
2022
Q2 | $9.66M | Buy |
143,844
+20,636
| +17% | +$1.39M | ﹤0.01% | 1533 |
|
|
2022
Q1 | $10.2M | Sell |
123,208
-18,823
| -13% | -$1.56M | ﹤0.01% | 1628 |
|
|
2021
Q4 | $20.8M | Sell |
142,031
-15,499
| -10% | -$2.27M | 0.01% | 1213 |
|
|
2021
Q3 | $27.9M | Sell |
157,530
-8,142
| -5% | -$1.44M | 0.01% | 1041 |
|
|
2021
Q2 | $26.8M | Sell |
165,672
-49,169
| -23% | -$7.94M | 0.01% | 1149 |
|
|
2021
Q1 | $36.8M | Buy |
214,841
+5,227
| +2% | +$895K | 0.01% | 905 |
|
|
2020
Q4 | $46M | Buy |
209,614
+17,351
| +9% | +$3.81M | 0.02% | 727 |
|
|
2020
Q3 | $31.9M | Buy |
192,263
+9,457
| +5% | +$1.57M | 0.01% | 789 |
|
|
2020
Q2 | $20.9M | Buy |
182,806
+6,210
| +4% | +$709K | 0.01% | 1018 |
|
|
2020
Q1 | $13.6M | Buy |
176,596
+53,401
| +43% | +$4.1M | 0.01% | 1111 |
|
|
2019
Q4 | $15.9M | Sell |
123,195
-900
| -0.7% | -$116K | 0.01% | 1307 |
|
|
2019
Q3 | $9.67M | Buy |
124,095
+14,222
| +13% | +$1.11M | ﹤0.01% | 1596 |
|
|
2019
Q2 | $11.3M | Buy |
+109,873
| New | +$11.3M | ﹤0.01% | 1520 |
|